TG103
A Study of TG103 Injection in Overweight/Obese Subjects Without Diabetes
CSPC Baike (Shandong) Biopharmaceutical Co · Phase 1 · Completed · Enrollment 48
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| TG103 injection 15 mg | T2D only | 15 mg | n/r | n/r | n/r |
| TG103 injection 22.5 mg | T2D only | 22.5 mg | n/r | n/r | n/r |
| TG103 injection 30 mg | T2D only | 30 mg | n/r | n/r | n/r |